Open access · OA
via OpenAlex
Age-Related Decline in Mesenchymal Stem Cells: Implications for Degenerative Disease Burden and Regenerative Medicine Strategies
Authors not listed
· 2025
Cellular senescence
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Stem-cell therapy
Human
Abstract
Mesenchymal stem/stromal cells (MSCs) exhibit the most dramatic age-related decline among adult stem cell populations, decreasing 100-to 1,000-fold in frequency and suffering profound functional impairment in proliferation, differentiation, immunomodulation, and paracrine activity.Normalized epidemiological data reveal a striking inverse relationship across the human lifespan: as MSC levels plummet between the third and sixth decades, the incidence and prevalence of major degenerative diseases; osteoarthritis requiring total knee/hip replacement, cardiovascular disease, and cancer, rise exponentially (Figure 1).Unlike hematopoietic, neural, muscle, or intestinal stem cells, which primarily undergo qualitative deterioration or protective quiescence while preserving cell numbers, MSCs experience both quantitative depletion and senescence(definition) without compensatory mechanisms.Their primary physiological role is not direct lineage replenishment but orchestration of tissue repair through secreted growth factors, anti-inflammatory mediators, and extracellular vesicles that support resident progenitor cells and resolve chronic inflammation.Many clinical trials now demonstrate that administration of culture-expanded autologous or allogeneic MSCs, particularly from younger donors, safely reduces pain and improves function in knee osteoarthritis, modestly enhances cardiac performance post-infarction, and induces remission in steroid-refractory inflammatory diseases, with effect size correlating with donor age and cell dose.These findings strongly suggest that the precipitous loss of functional MSCs constitutes a pivotal, upstream bottleneck in endogenous regenerative capacity and a rational cross-disease therapeutic target.Strategies to restore youthful MSC activity via allogeneic cells from perinatal sources, pharmacological mobilisation, exosome-based therapeutics, or rejuvenation of autologous cells hold promise for mitigating the escalating burden of age-related degenerative pathology and warrant prioritisation in late-stage clinical investigation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.56831/pssrp-07-234
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Anonymous. (2025). Age-Related Decline in Mesenchymal Stem Cells: Implications for Degenerative Disease Burden and Regenerative Medicine Strategies. https://doi.org/10.56831/pssrp-07-234
Vancouver
Anonymous. Age-Related Decline in Mesenchymal Stem Cells: Implications for Degenerative Disease Burden and Regenerative Medicine Strategies. 2025. doi:10.56831/pssrp-07-234.
BibTeX
@article{anon2025AgeRel,
title = {Age-Related Decline in Mesenchymal Stem Cells: Implications for Degenerative Disease Burden and Regenerative Medicine Strategies},
author = {Anonymous},
year = {2025},
doi = {10.56831/pssrp-07-234},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cold Spring Harbor Symposia on Quantitative Biology 2005
Preprint · OA
Stem Cell Self-Renewal and Cancer Cell Proliferation Are Regulated by Common Networks That Balance the Activation of Proto-oncogenes and Tumor Suppressors
Innovation in Aging 2018
Open access · OA
CELLULAR SENESCENCE, AGING, AND CANCER
Stem Cells International 2018
Open access · CC-BY
Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
Cell Biology International 2012
Citation only
Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti‐apoptosis capabilities
Circulation Research 2011
Open access · OA
Mesenchymal Stem Cells: Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease
Korean journal of family medicine 2025
Open access · OA